Blood test shows promise for early ovarian cancer detection with 88-93% accuracy

Ovarian cancer affects approximately 7,500 women annually in the UK, with late detection reducing treatment effectiveness and survival outcomes.

Each year, thousands of women in the UK receive an ovarian cancer diagnosis too late — not because medicine failed to look, but because the disease offers so few early signs worth seeing. Researchers at the universities of Manchester and Colorado have now developed a blood test that reads the molecular fingerprints cancer leaves behind, using machine learning to detect the disease with up to 93% accuracy even in its earliest stages. It is a quiet but significant shift in the long struggle against a cancer that has always hidden well — one that, if it clears regulatory approval, could give medi

Blood test shows promise for early ovarian cancer detection with 88-93% accuracy

Cobertura Relacionada

Recibe The Register en tu bandeja